Northern Trust Portfolio holdings
AUM
$727B
1-Year Return
23.08%
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
This Quarter Return
+9.22%
1 Year Return
+23.08%
3 Year Return
+97.56%
5 Year Return
+177.34%
10 Year Return
+414.74%
AUM
$504B
AUM Growth
+$27.9B
(+5.8%)
Cap. Flow
-$1.68B
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
4,718
New
74
Increased
2,222
Reduced
2,007
Closed
140
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$296M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$192M |
| 3 |
Costco
COST
|
+$106M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$102M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$302M |
| 2 |
PACCAR
PCAR
|
+$236M |
| 3 |
Apple
AAPL
|
+$189M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$160M |
| 5 |
Amazon
AMZN
|
+$156M |
Sector Composition
| 1 | Technology | 23.61% |
| 2 | Healthcare | 12.95% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Neurogene
NGNE
$265M
| $48.8K | ﹤0.01% |
3,488
| – | – |
|
|
DOYU
4277
DouYu International Holdings
DOYU
$244M
| $48.8K | ﹤0.01% |
4,100
-210
| -5% | -$2.5K |
|
|
ORGS
4278
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $48.6K | ﹤0.01% |
4,123
+500
| +14% | +$5.9K |
|
4279
MEI Pharma
MEIP
$101M
| $48.4K | ﹤0.01% |
10,578
-154
| -1% | -$705 |
|
4280
Educational Development Corp
EDUC
$9.53M
| $47.5K | ﹤0.01% |
16,160
+640
| +4% | +$1.88K |
|
|
SANW
4281
DELISTED
S&W Seed Co
SANW
| $47.4K | ﹤0.01% |
1,728
+236
| +16% | +$6.48K |
|
4282
NRX Pharmaceuticals
NRXP
$70.6M
| $47K | ﹤0.01% |
7,124
+1,264
| +22% | +$8.33K |
|
|
MKUL
4283
DELISTED
Molekule Group, Inc. Common Stock
MKUL
| $46.3K | ﹤0.01% |
27,409
+16,167
| +144% | +$27.3K |
|
|
CTHR
4284
DELISTED
Charles & Colvard Ltd
CTHR
| $45.1K | ﹤0.01% |
4,850
| – | – |
|
|
IMAB
4285
I-MAB
IMAB
$341M
| $45.1K | ﹤0.01% |
13,033
| – | – |
|
4286
Zedge
ZDGE
$40.1M
| $44.4K | ﹤0.01% |
22,765
| – | – |
|
|
NOVN
4287
DELISTED
Novan, Inc. Common Stock
NOVN
| $44.4K | ﹤0.01% |
34,121
+8,295
| +32% | +$10.8K |
|
4288
Houston American Energy
HUSA
$256M
| $43.6K | ﹤0.01% |
1,682
| – | – |
|
4289
Senti Biosciences
SNTI
$34M
| $43.5K | ﹤0.01% |
3,685
+2,255
| +158% | +$26.6K |
|
4290
Bolt Biotherapeutics
BOLT
$10.1M
| $43.3K | ﹤0.01% |
1,559
-55
| -3% | -$1.53K |
|
4291
SELLAS Life Sciences
SLS
$198M
| $42.9K | ﹤0.01% |
30,018
-7,653
| -20% | -$10.9K |
|
4292
Knightscope
KSCP
$56.6M
| $42.2K | ﹤0.01% |
948
+341
| +56% | +$15.2K |
|
4293
Alzamend Neuro
ALZN
$7.38M
| $42.1K | ﹤0.01% |
73
| – | – |
|
4294
a.k.a. Brands
AKA
$114M
| $42.1K | ﹤0.01% |
6,440
-954
| -13% | -$6.24K |
|
|
ORKA
4295
Oruka Therapeutics, Inc. Common Stock
ORKA
$591M
| $41.8K | ﹤0.01% |
1,749
+289
| +20% | +$6.9K |
|
|
SI
4296
DELISTED
Silvergate Capital Corporation
SI
| $41.6K | ﹤0.01% |
25,699
-255,042
| -91% | -$413K |
|
4297
Applied Therapeutics
APLT
$64M
| $41.3K | ﹤0.01% |
50,960
| – | – |
|
4298
Sypris Solutions
SYPR
$44.9M
| $41.3K | ﹤0.01% |
20,944
| – | – |
|
4299
Ekso Bionics
EKSO
$10.5M
| $41.2K | ﹤0.01% |
1,664
+303
| +22% | +$7.5K |
|
4300
SOBR Safe
SOBR
$4.87M
| $41K | ﹤0.01% |
17
| – | – |
|